Cardiovascular risk assessment and cholesterol management have evolved. This article breaks down the latest recommendations into practical, easy-to-follow steps. I am not including heavily clinical details such as calculators to use, details of escalating lipid lowering treatment, etc which is a clinical decision. This article is to make screening and initial steps easy for patients and physicians.
1. Start With Better Risk Assessment
- Measure Lp(a) at least once in all adults
- Consider apoB in high-risk patients ASCVD, cardio-kidney metabolic syndrome, type 2 diabetes, and high triglycerides
- Use 10-year PREVENT ASCVD risk calculator (ages 30–79)
Risk Categories:
- Low: <3%
- Borderline: 3–5%
- Intermediate: 5–10%
- High: ≥10%
2. When Risk Is Unclear → Use Coronary Artery Calcium (CAC) Score
If you’re unsure about starting statins:
- CAC = 0 → consider delaying medication (if no major risk factors)
- CAC >0 → consider treatment
- CAC ≥100 → start statin strongly recommended
3. LDL Goals
| Patient Group | LDL Goal |
| General prevention | <100 mg/dL |
| Diabetes | <100 mg/dL |
| ASCVD (not very high risk) | <70 mg/dL |
| Very high risk ASCVD | <55 mg/dL |
4. Who Needs Statins?
- LDL ≥190 mg/dL → Always treat
- Diabetes (age 40–75) → Statin indicated
- Known cardiac events → High-intensity statin
- Treatment will always consider risk enhancers + CAC regardless of risk score.
5. Very High-Risk Patients
You are VERY HIGH RISK if:
- Established cardiac event +
- Multiple prior events OR
- One event + multiple high-risk conditions
Goal:
➡️ LDL <55 mg/dL
➡️ Non-HDL <85 mg/dL
6. Risk Enhancers
Helpful to assess chances of cardiac events in low and borderline risk patients:
Clinical Risk Enhancers
- Family history of premature cardiac events
- Chronic kidney disease
- Metabolic syndrome
- Chronic inflammatory/autoimmune conditions
- South Asian ancestry
Reproductive Risk Factors
- Early menopause (<45 years)
- Preeclampsia
- Gestational diabetes
- Preterm delivery
Laboratory Risk Enhancers
- Lp(a) elevated
- hs-CRP ≥2 mg/L (persistent)
- Elevated apoB
- High triglycerides
7. Severe Hypercholesterolemia (LDL ≥190)
- Evaluate for familial hypercholesterolemia (FH)
- Consider genetic testing
- If statin not enough → add:
- Ezetimibe
- PCSK9 inhibitors
- Bempedoic acid
8. Supplements: Clear Recommendation
- ❌ Not recommended for lowering LDL or reducing cardiovascular risk
- Evidence is inconsistent and limited
9. Special Populations
- Cancer survivors → treat like general population
- CKD (Stage ≥3) → aggressive lipid lowering
- Incidental coronary calcium noted on CT scan → treat as real risk
10. Practical Takeaways
- Don’t rely on LDL alone → use Lp(a), apoB, CAC
- Borderline risk is where most mistakes happen
- CAC score is your tie-breaker
- Very high-risk patients need aggressive targets (<55 LDL)
- Lifestyle always matters—but medications save lives when indicated
This article is meant for educational purposes, not a medical advice.
Dr. Anusha Bhat, MD MPH
Cardiologist | Cardio-oncologist